Term Gallery logo

Significats de bortezomib en anglès

rus
бортезомиб
portuguès
bortezomibe
espanyol
bortezomib

Chemical compound.

Termes relacionats
бортезомиб
Ús de bortezomib en anglès
1
These biomarkers data begin to illuminate bortezomib's mechanism of action in lymphoma.
Pubmed
2
Results: Thirty-one per cent of patients received bortezomib beyond first relapse.
Pubmed
3
However, apoptotic response to bortezomib was not affected by the deletion of p53.
Pubmed
4
Recently, it has been shown that bortezomib treatment enhances OB function.
Pubmed
5
The safety profile was consistent with that reported for single-agent bortezomib and romidepsin.
Pubmed
6
These data suggest that bortezomib-induced plasma cell depletion triggers humoral compensation.
Pubmed
7
We tested the signature in independent cohorts treated with bortezomib- and lenalidomide-based therapies.
Pubmed
8
After repeated treatment, initially sensitive lung tumors became resistant to bortezomib.
Pubmed
9
The synergistic interaction between oHSV and bortezomib was calculated using a Chou-Talalay analysis.
Pubmed
10
The combination of bortezomib and IFN-a can be safely administered to melanoma patients.
Pubmed
11
The proteasome inhibitor bortezomib is an efficacious apoptotic agent in many tumor cells.
Pubmed
12
The degree of proteasome inhibition was similar to that reported with single-agent bortezomib.
Pubmed
13
When possible, all subsequent doses of bortezomib within each cycle were provided at home.
Pubmed
14
Conversely, none of the patients who received a treatment without bortezomib developed muscular symptoms.
Pubmed
15
Conclusion: Both bortezomib plus rituximab regimens seem feasible in relapsed or refractory indolent lymphomas.
Pubmed
16
This delineates another therapeutic mechanism of bortezomib in T-cell malignancies.
Pubmed
Sobre aquest terme
Més col·locacions
Translations for bortezomib
espanyol
bortezomib
Bortezomib a través del temps
Bortezomib per variant geogràfica
Estats Units d'Amèrica
Comú